BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34039664)

  • 1. Protein tyrosine phosphatase receptor type C (PTPRC or CD45).
    Al Barashdi MA; Ali A; McMullin MF; Mills K
    J Clin Pathol; 2021 Sep; 74(9):548-552. PubMed ID: 34039664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.
    Kresinsky A; Schnöder TM; Jacobsen ID; Rauner M; Hofbauer LC; Ast V; König R; Hoffmann B; Svensson CM; Figge MT; Hilger I; Heidel FH; Böhmer FD; Müller JP
    Oncogene; 2019 Jun; 38(24):4773-4787. PubMed ID: 30820040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the transmembrane protein tyrosine phosphatase CD45.
    Sasaki T; Sasaki-Irie J; Penninger JM
    Int J Biochem Cell Biol; 2001 Nov; 33(11):1041-6. PubMed ID: 11551820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
    Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
    Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.
    Al Barashdi MAS; Ali A; McMullin MF; Mills K
    Ann Hematol; 2024 Jan; 103(1):73-88. PubMed ID: 37917373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
    Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
    J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45.
    Saunders AE; Johnson P
    Cell Signal; 2010 Mar; 22(3):339-48. PubMed ID: 19861160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple components of the B cell antigen receptor complex associate with the protein tyrosine phosphatase, CD45.
    Brown VK; Ogle EW; Burkhardt AL; Rowley RB; Bolen JB; Justement LB
    J Biol Chem; 1994 Jun; 269(25):17238-44. PubMed ID: 7516335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines.
    Nakano A; Harada T; Morikawa S; Kato Y
    Acta Pathol Jpn; 1990 Feb; 40(2):107-15. PubMed ID: 2140233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45 regulated signaling pathways.
    Irie-Sasaki J; Sasaki T; Penninger JM
    Curr Top Med Chem; 2003; 3(7):783-96. PubMed ID: 12678844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.
    Ng DH; Jabali MD; Maiti A; Borodchak P; Harder KW; Brocker T; Malissen B; Jirik FR; Johnson P
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):867-76. PubMed ID: 9581568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deletion in the gene encoding the CD45 antigen in a patient with SCID.
    Tchilian EZ; Wallace DL; Wells RS; Flower DR; Morgan G; Beverley PC
    J Immunol; 2001 Jan; 166(2):1308-13. PubMed ID: 11145714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.
    Koretzky GA; Picus J; Schultz T; Weiss A
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2037-41. PubMed ID: 1672451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine-phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells.
    Stover DR; Charbonneau H; Tonks NK; Walsh KA
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7704-7. PubMed ID: 1652760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase.
    Mustelin T; Coggeshall KM; Altman A
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6302-6. PubMed ID: 2548204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45.
    Greer SF; Lin J; Clarke CH; Justement LB
    J Biol Chem; 1998 May; 273(19):11970-9. PubMed ID: 9565626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.
    Irie-Sasaki J; Sasaki T; Matsumoto W; Opavsky A; Cheng M; Welstead G; Griffiths E; Krawczyk C; Richardson CD; Aitken K; Iscove N; Koretzky G; Johnson P; Liu P; Rothstein DM; Penninger JM
    Nature; 2001 Jan; 409(6818):349-54. PubMed ID: 11201744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tyrosine phosphatase CD45 in apoptosis.
    Dupéré-Minier G; Desharnais P; Bernier J
    Apoptosis; 2010 Jan; 15(1):1-13. PubMed ID: 19856105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Tyrosine Phosphatase CD45 As an Immunity Regulator and a Potential Effector of CAR-T therapy.
    Volkov DV; Stepanova VM; Rubtsov YP; Stepanov AV; Gabibov AG
    Acta Naturae; 2023; 15(3):17-26. PubMed ID: 37908772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.